Learn more

CUSI LAB

Overview
  • Total Patents
    113
About

CUSI LAB has a total of 113 patent applications. Its first patent ever was published in 1975. It filed its patents most often in Spain, United States and Japan. Its main competitors in its focus markets pharmaceuticals, machines and organic fine chemistry are GEBRO BROSCHEK GMBH, INST OF HIGH ENERGY PHYSICS CH and BAE IL JU.

Patent filings per year

Chart showing CUSI LABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Vallet Mas Jose Alberto 32
#2 Bergamini Michael Van Wie 17
#3 Carreras Perdiguer Nuria 14
#4 Galan Valdivia Francisco Javie 12
#5 Gimenez Guasch Francesc Xavier 11
#6 Lopez Cabrera Antonio 10
#7 Coll Colomer Jordi 9
#8 Guasch Francesc Xavier Gimenez 7
#9 Torrella Cabello Gemma 7
#10 Mas Jose Alberto Vallet 6

Latest patents

Publication Filing date Title
ES2128220A1 Pharmaceutical container of two separate substances, with mixing device, dosage application and its assembly process.
ES2094688A1 Manoemulsion of the type of oil in water, useful as an ophthalmic vehicle and procedure for its preparation.
FI943066A0 Use of polymer membranes in the distribution of pharmaceutical solutions containing quaternary ammonium compounds as preservatives
ES2078194A1 Improvements introduced in container containers of products of two components that have to be mixed for their administration.
ES2078190A1 Procedure for the coating of goticles or particles of nanometric size.
ES2079320A1 Ophthalmic dissolution based on a diclofenaco and tobramycin and its applications.
ES2074402A1 Pharmaceutical formulation containing difenhydramine, talco, calamine and oat extract, in an emulsified base, and its applications.
ES2078175A1 Pharmaceutical formulation containing clobetasone and tobramycin and its applications.
ES2098176A1 Bottle for storing two products in a double compartment with a mixing device and dosed dispensation.
ES2064286A1 New application of polymeric membranes in the dispensation of pharmaceutical solutions containing quaternary ammonium compounds as conservatives and the corresponding dispenser container.
EP0577200A1 Pharmaceutical product container for two separate substances, having a device for mixing and dosed dispensation
ES2065846A1 Pharmaceutical formulation based on a steroid or non-steroid anti-inflammatory agent and an antibiotic belonging to the girase dna inhibitors group for its topical ophthalmic use.
ES2070076A1 Method to increase the stability of nanocapsules during storage.
ES2064277A1 Pharmaceutical products container, with two separate substances and mixing device and dispensed dosage.
ES2079994A1 Pharmaceutical formulation based on polymixine-trimetoprim and an anti-inflammatory agent for its topical ophthalmic and ethical use.
ES2034891A1 Continuous elaboration procedure of scattered colloid systems, in the form of nanocapsules or nanoparticles.
US5308624A Ophthalmic product
ES2012532A6 Ophthalmic aqueous solutions containing lysine- alpha -methyl-4-(2'-thionylcarbonyl) phenyl acetate
ES8606332A1 Fluoro-benzyl methoxy-phenethyl piperidyl-amino benzimidazole prepn.
ES8303387A1 Procedure for obtaining 4-phenoxy-3- (1-pirrolidinyl) -5-sulfamoilbenzoic acid from 3 amino-4-fenoxi-5-sulfamoilbenzoic acid.